Biblio
Export 752 results:
Author Title Type [ Year![(Asc)](https://www.j-alz.com/sites/all/modules/contrib/biblio/misc/arrow-asc.png)
Filters: First Letter Of Keyword is P [Clear All Filters]
“SIRT1 Deacetylates SC35 and Suppresses Its Function in Tau Exon 10 Inclusion.”, J Alzheimers Dis, vol. 61, no. 2, pp. 561-570, 2018.
, “SORL1 Variants in Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1275-1281, 2018.
, “SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging.”, J Alzheimers Dis, vol. 61, no. 1, pp. 401-414, 2018.
, “SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging.”, J Alzheimers Dis, vol. 61, no. 1, pp. 401-414, 2018.
, “Synthetic Fragment of Receptor for Advanced Glycation End Products Prevents Memory Loss and Protects Brain Neurons in Olfactory Bulbectomized Mice.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1061-1076, 2018.
, “Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 2, pp. 509-513, 2018.
, “Tauopathies: Mechanisms and Therapeutic Strategies.”, J Alzheimers Dis, vol. 61, no. 2, pp. 487-508, 2018.
, “Tauopathies: Mechanisms and Therapeutic Strategies.”, J Alzheimers Dis, vol. 61, no. 2, pp. 487-508, 2018.
, “Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 221-236, 2018.
, “Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 221-236, 2018.
, “The Uniform Data Set, Czech Version: Normative Data in Older Adults from an International Perspective.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1233-1240, 2018.
, “Vestibular Loss Predicts Poorer Spatial Cognition in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 995-1003, 2018.
, “Visit-To-Visit Blood Pressure Variability and the Risk of Dementia in Older People.”, J Alzheimers Dis, vol. 62, no. 2, pp. 727-735, 2018.
, “White Matter Hyperintensity Predicts the Risk of Incident Cognitive Decline in Community Dwelling Elderly.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1333-1341, 2018.
, “White Matter Hyperintensity Predicts the Risk of Incident Cognitive Decline in Community Dwelling Elderly.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1333-1341, 2018.
, “Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference?”, J Alzheimers Dis, vol. 61, no. 1, pp. 47-52, 2018.
, “18F-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 57, no. 3, pp. 711-716, 2017.
, “Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.”, J Alzheimers Dis, vol. 57, no. 3, pp. 765-773, 2017.
, “Exercise Training and Functional Connectivity Changes in Mild Cognitive Impairment and Healthy Elders.”, J Alzheimers Dis, vol. 57, no. 3, pp. 845-856, 2017.
, “Family History of Alzheimer's Disease is Associated with Impaired Perceptual Discrimination of Novel Objects.”, J Alzheimers Dis, vol. 57, no. 3, pp. 735-745, 2017.
, “Family History of Alzheimer's Disease is Associated with Impaired Perceptual Discrimination of Novel Objects.”, J Alzheimers Dis, vol. 57, no. 3, pp. 735-745, 2017.
, “Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity.”, J Alzheimers Dis, vol. 57, no. 3, pp. 857-871, 2017.
, “Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity.”, J Alzheimers Dis, vol. 57, no. 3, pp. 857-871, 2017.
, “Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier.”, J Alzheimers Dis, vol. 57, no. 3, pp. 697-703, 2017.
, “Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier.”, J Alzheimers Dis, vol. 57, no. 3, pp. 697-703, 2017.
,